STAAR Surgical Debt to Equity Ratio 2010-2023 | STAA

Current and historical debt to equity ratio values for STAAR Surgical (STAA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. STAAR Surgical debt/equity for the three months ending December 31, 2023 was 0.00.
STAAR Surgical Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-12-31 $0.10B $0.39B 0.27
2023-09-30 $0.09B $0.38B 0.25
2023-06-30 $0.09B $0.35B 0.25
2023-03-31 $0.08B $0.34B 0.24
2022-12-31 $0.08B $0.34B 0.25
2022-09-30 $0.08B $0.32B 0.23
2022-06-30 $0.08B $0.30B 0.26
2022-03-31 $0.08B $0.28B 0.27
2021-12-31 $0.09B $0.26B 0.34
2021-09-30 $0.08B $0.25B 0.30
2021-06-30 $0.06B $0.24B 0.26
2021-03-31 $0.05B $0.21B 0.24
2020-12-31 $0.06B $0.20B 0.31
2020-09-30 $0.05B $0.19B 0.26
2020-06-30 $0.04B $0.18B 0.25
2020-03-31 $0.04B $0.17B 0.25
2019-12-31 $0.05B $0.16B 0.30
2019-09-30 $0.04B $0.15B 0.29
2019-06-30 $0.04B $0.14B 0.29
2019-03-31 $0.04B $0.14B 0.29
2018-12-31 $0.04B $0.13B 0.26
2018-09-30 $0.03B $0.13B 0.27
2018-06-30 $0.03B $0.05B 0.62
2018-03-31 $0.03B $0.05B 0.71
2017-12-31 $0.03B $0.04B 0.58
2017-09-30 $0.03B $0.04B 0.79
2017-06-30 $0.03B $0.04B 0.66
2017-03-31 $0.03B $0.04B 0.77
2016-12-31 $0.03B $0.04B 0.73
2016-09-30 $0.03B $0.04B 0.76
2016-06-30 $0.03B $0.04B 0.72
2016-03-31 $0.02B $0.04B 0.61
2015-12-31 $0.02B $0.04B 0.62
2015-09-30 $0.02B $0.04B 0.57
2015-06-30 $0.02B $0.04B 0.52
2015-03-31 $0.02B $0.04B 0.56
2014-12-31 $0.02B $0.04B 0.59
2014-09-30 $0.02B $0.04B 0.55
2014-06-30 $0.02B $0.04B 0.54
2014-03-31 $0.02B $0.04B 0.56
2013-12-31 $0.02B $0.04B 0.59
2013-09-30 $0.02B $0.04B 0.57
2013-06-30 $0.02B $0.04B 0.58
2013-03-31 $0.02B $0.03B 0.61
2012-12-31 $0.02B $0.03B 0.73
2012-09-30 $0.02B $0.03B 0.59
2012-06-30 $0.02B $0.03B 0.58
2012-03-31 $0.02B $0.03B 0.58
2011-12-31 $0.02B $0.03B 0.66
2011-09-30 $0.02B $0.03B 0.62
2011-06-30 $0.02B $0.03B 0.67
2011-03-31 $0.02B $0.02B 0.72
2010-12-31 $0.02B $0.02B 0.81
2010-09-30 $0.02B $0.02B 0.78
2010-06-30 $0.02B $0.02B 0.72
2010-03-31 $0.03B $0.02B 1.41
2009-12-31 $0.04B $0.02B 1.79
2009-09-30 $0.04B $0.02B 1.64
2009-06-30 $0.04B $0.02B 1.55
2009-03-31 $0.04B $0.01B 2.46
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.267B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.967B 18.46
Becton Dickinson (BDX) United States $67.638B 19.64
West Pharmaceutical Services (WST) United States $27.235B 46.04
Cardinal Health (CAH) United States $26.315B 15.82
Align Technology (ALGN) United States $22.499B 45.37
Cooper (COO) United States $17.972B 27.19
Labcorp (LH) United States $16.950B 14.47
Henry Schein (HSIC) United States $9.104B 15.75
DENTSPLY SIRONA (XRAY) United States $6.325B 16.67
Merit Medical Systems (MMSI) United States $4.182B 23.93
Patterson (PDCO) United States $2.331B 11.17
CONMED (CNMD) United States $2.237B 21.06
Atrion (ATRI) United States $0.708B 36.48
Lifevantage (LFVN) United States $0.086B 13.96
Pro-Dex (PDEX) United States $0.067B 25.33
Biolase (BIOL) United States $0.005B 0.00